47 related articles for article (PubMed ID: 38743086)
1. Chronic lymphocytic leukemia with deletion 17p: An Indian scenario.
Gogia A; Gupta R; Kumar L; Sharma A; Soni L
South Asian J Cancer; 2019; 8(1):40. PubMed ID: 30766851
[No Abstract] [Full Text] [Related]
2. Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.
Fontecha MB; Anadón MDR; Mercado Guzmán V; Stanganelli C; Galvano C; Tosin F; Bordone J; Bezares R; Rodríguez C; Heller V; Slavutsky I; Fundia AF
Ann Hematol; 2024 May; ():. PubMed ID: 38743086
[TBL] [Abstract][Full Text] [Related]
3.
Ounalli A; Moumni I; Mechaal A; Chakroun A; Barmat M; Rhim REE; Menif S; Safra I
Front Oncol; 2023; 13():1272876. PubMed ID: 37909012
[TBL] [Abstract][Full Text] [Related]
4. The Underestimated Role of the p53 Pathway in Renal Cancer.
Amendolare A; Marzano F; Petruzzella V; Vacca RA; Guerrini L; Pesole G; Sbisà E; Tullo A
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497215
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
De Luca G; Cerruti G; Lastraioli S; Conte R; Ibatici A; Di Felice N; Morabito F; Monti P; Fronza G; Matis S; Colombo M; Fabris S; Ciarrocchi A; Neri A; Menichini P; Ferrarini M; Nozza P; Fais F; Cutrona G; Dono M
Hematol Oncol; 2022 Dec; 40(5):962-975. PubMed ID: 35961859
[TBL] [Abstract][Full Text] [Related]
6. p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways.
Lindström MS; Bartek J; Maya-Mendoza A
Cell Death Differ; 2022 May; 29(5):972-982. PubMed ID: 35444234
[TBL] [Abstract][Full Text] [Related]
7. Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia
Soussi T; Baliakas P
Front Oncol; 2022; 12():808886. PubMed ID: 35251978
[TBL] [Abstract][Full Text] [Related]
8. p53 p.Pro72Arg (rs1042522) and Mouse Double Minute 2 (MDM2) Single-Nucleotide Polymorphism (SNP) 309 Variants and Their Interaction in Chronic Lymphocytic Leukemia(CLL): A Survey in CLL Patients from Western Iran.
Jalilian N; Maleki Y; Shakiba E; Aznab M; Rahimi Z; Salimi M; Rhimi Z
Int J Hematol Oncol Stem Cell Res; 2021 Jul; 15(3):160-169. PubMed ID: 35082997
[No Abstract] [Full Text] [Related]
9. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.
Hallek M; Al-Sawaf O
Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994
[TBL] [Abstract][Full Text] [Related]
10. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.
Zhang P; Kitchen-Smith I; Xiong L; Stracquadanio G; Brown K; Richter PH; Wallace MD; Bond E; Sahgal N; Moore S; Nornes S; De Val S; Surakhy M; Sims D; Wang X; Bell DA; Zeron-Medina J; Jiang Y; Ryan AJ; Selfe JL; Shipley J; Kar S; Pharoah PD; Loveday C; Jansen R; Grochola LF; Palles C; Protheroe A; Millar V; Ebner DV; Pagadala M; Blagden SP; Maughan TS; Domingo E; Tomlinson I; Turnbull C; Carter H; Bond GL
Cancer Res; 2021 Apr; 81(7):1667-1680. PubMed ID: 33558336
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.
Delgado J; Nadeu F; Colomer D; Campo E
Haematologica; 2020 Sep; 105(9):2205-2217. PubMed ID: 33054046
[TBL] [Abstract][Full Text] [Related]
12. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.
Morabito F; Gentile M; Monti P; Recchia AG; Menichini P; Skafi M; Atrash M; De Luca G; Bossio S; Al-Janazreh H; Galimberti S; Salah Z; Morabito L; Mujahed A; Hindiyeh M; Dono M; Fais F; Cutrona G; Neri A; Tripepi G; Fronza G; Ferrarini M
Expert Opin Investig Drugs; 2020 Aug; 29(8):869-880. PubMed ID: 32551999
[TBL] [Abstract][Full Text] [Related]
13. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
14. Analysis of basal chromosome instability in patients with chronic lymphocytic leukaemia.
Palmitelli M; Stanganelli C; Stella F; Krzywinski A; Bezares R; González Cid M; Slavutsky I
Mutagenesis; 2019 Sep; 34(3):245-252. PubMed ID: 31037299
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia.
Maleki Y; Alahbakhshi Z; Heidari Z; Moradi MT; Rahimi Z; Yari K; Rahimi Z; Aznab M; Ahmadi-Khajevand M; Bahremand F
Oncol Lett; 2019 Apr; 17(4):4016-4023. PubMed ID: 30930998
[TBL] [Abstract][Full Text] [Related]
16.
Campo E; Cymbalista F; Ghia P; Jäger U; Pospisilova S; Rosenquist R; Schuh A; Stilgenbauer S
Haematologica; 2018 Dec; 103(12):1956-1968. PubMed ID: 30442727
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V
Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344
[TBL] [Abstract][Full Text] [Related]
18. Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Baliakas P; Moysiadis T; Hadzidimitriou A; Xochelli A; Jeromin S; Agathangelidis A; Mattsson M; Sutton LA; Minga E; Scarfò L; Rossi D; Davis Z; Villamor N; Parker H; Kotaskova J; Stalika E; Plevova K; Mansouri L; Cortese D; Navarro A; Delgado J; Larrayoz M; Young E; Anagnostopoulos A; Smedby KE; Juliusson G; Sheehy O; Catherwood M; Strefford JC; Stavroyianni N; Belessi C; Pospisilova S; Oscier D; Gaidano G; Campo E; Haferlach C; Ghia P; Rosenquist R; Stamatopoulos K;
Haematologica; 2019 Feb; 104(2):360-369. PubMed ID: 30262567
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
